Disc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia Vera
Disc Medicine, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of…
sciencecitySeptember 22, 2023











